A Prospective, Single-center, Randomized Controlled Trial Comparing the Efficacy and Safety of High Freqnence Irreversible Electroporation and Trans Urethral Resection Prostate for Benign Prostatic Hyperplasia
Status: Recruiting
Location: See location...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
This trial is comparing the effects and safety in treating men with benign prostatic hyperplasia between high freqnence irreversible electroporation and trans urethral resection prostate.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 40
Healthy Volunteers: t
View:
• Age over 40 years old
• IPSS\>8
• Qmax \<15ml/s
• Prostatic volume range of 30 to 100ml, measured by MRI
• Fully understand the clinical trial protocol and sign the informed consent
Locations
Other Locations
China
Haifeng Wang
RECRUITING
Shanghai
Contact Information
Primary
Biming He
190589109@qq.com
+8615502139410
Backup
Haifeng Wang
446720864@qq.com
+8613681750891
Time Frame
Start Date: 2022-06-30
Estimated Completion Date: 2026-04-01
Participants
Target number of participants: 118
Treatments
Experimental: High Freqnence Irreversible Electroporation
Using high freqnence irreversible electroporation to treat patients with benign prostatic hyperplasia
Active_comparator: Trans Urethral Resection Prostate
Using trans urethral resection prostate to treat patients with benign prostatic hyperplasia
Related Therapeutic Areas
Sponsors
Leads: Shanghai East Hospital